Delhi · Gurugram · Bangalore · Baddi · Bahadurgarh

Medical Device Packaging Validation — ISO 11607:2019

The sterile barrier system (SBS) is the last line of defence between a validated sterilisation process and patient use — a packaging failure invalidates every upstream sterilisation, bioburden, and ETO-residuals control. Auriga Research provides NABL-accredited medical device packaging validation per ISO 11607-1:2019 and ISO 11607-2:2019, the current harmonised editions referenced under EU MDR, FDA recognised consensus standards, and CDSCO MDR 2017.

Our scope covers seal strength (ASTM F88), burst integrity (ASTM F1140 / F2054), dye penetration (ASTM F1929), visual inspection (ASTM F1886), bubble emission (ASTM F2096), microbial barrier (ISO 11607-1 Annex B), Tyvek and film tensile, and the full accelerated ageing per ASTM F1980 workflow with concurrent real-time controls — durations calculated against the Q10 / reference-temperature parameters defined in your validation protocol and product specification. Distribution simulation runs per ASTM D4169 or the ISTA 2A / 3A protocols depending on the target market.

Packaging validation is a prerequisite for any sterility claim — it is requested alongside bioburden, ETO residuals, and sterility testing on every sterile-device submission. Backed by the Arbro Group's analytical heritage — Arbro Lab since 1990, Auriga Research since 2007 — with NABL ISO/IEC 17025 accreditation, our reports are accepted by CDSCO, FDA 510(k), and EU CE Notified Bodies, and are formatted for direct attachment to the sterilisation / sterility section of the technical file.

Seal & burst tests 5–7 days | Accelerated ageing duration per client validation protocol

Get a Quote Call +91-7428116100

Packaging Testing Scope

Each test is mapped to its ISO 11607 part or ASTM method so QA and regulatory teams can match scope to the sterile barrier validation file at a glance.

ISO 11607-1

SBS & Material Requirements

Sterile barrier system and material requirements per ISO 11607-1:2019.

ISO 11607-2

Process Validation

Forming, sealing, and assembly process validation per ISO 11607-2:2019.

ASTM F88

Seal Strength

Peel testing per ASTM F88 — heat-seal consistency and adequacy as a process-control parameter.

ASTM F1140 / F2054

Burst Testing

Unrestrained (ASTM F1140) and restrained (ASTM F2054) internal-pressure burst integrity.

ASTM F1929

Dye Penetration

Dye penetration seal-integrity test per ASTM F1929 for channel-leak detection.

ASTM F1886

Visual Inspection

Visual seal inspection for defects per ASTM F1886.

ASTM F2096

Bubble Emission

Whole-package integrity by bubble emission (internal pressurisation) per ASTM F2096.

ISO 11607-1 Annex B

Microbial Barrier

Microbial barrier testing of porous packaging materials per ISO 11607-1 Annex B.

ASTM F1980

Accelerated Ageing

Accelerated ageing per the Q10 / Arrhenius relationship — duration calculated against the client validation protocol and product specification.

Real-Time

Real-Time Ageing

Concurrent real-time ageing to progressively confirm the accelerated shelf-life result.

ASTM D4169 / ISTA

Distribution Simulation

Transport / distribution simulation per ASTM D4169 and ISTA 2A / 3A for domestic and export packaging.

Tensile

Tyvek & Film Tensile

Tyvek and film tensile strength and elongation for material qualification.

How It Works

Get a Quote

Share your device type, sterile barrier system design (Tyvek / film pouch, formed tray with lid stock, blister, etc.), sterilisation method, shelf-life claim (1–5 years), and target market (CDSCO / FDA / CE). Your dedicated SPOC confirms the test set — ASTM F88 / F1140 / F1929 / F1886, the ASTM F1980 ageing matrix, and any distribution-simulation overlay — and the sample quantity required before you dispatch anything.

Send Your Sample

Dispatch finished, sealed packages from the validation lots with a completed Test Request Form to the nearest Auriga lab. Each sample is individually bar coded and registered in YLIMS, Auriga's in-house Laboratory Information Management System, upon receipt. Initial testing begins within 24 hours of sample registration; ageing chambers are loaded the same day for time-point control.

Testing and QA Review

Your samples are tested per the validated ISO 11607 / ASTM methods by Auriga's medical device packaging team. Every result — seal strength, burst, dye penetration, visual inspection, and the post-ageing repeats — passes through a formal internal QA review against the acceptance criteria you nominated in the BEP / validation protocol before the report is generated.

Receive Your NABL Report

Your NABL-accredited packaging validation report is delivered digitally within the committed turnaround time (with time-point reports issued progressively for long-running ageing programmes). Reports carry Auriga's NABL accreditation under ISO/IEC 17025:2017, cite the exact ISO 11607 part / edition and ASTM revisions applied, and are accepted by CDSCO, FDA 510(k), and CE Notified Bodies. You can track sample and chamber status in real time through YLIMS.

Turnaround Time

Service	Standard TAT	Express
Seal strength (ASTM F88), burst (F1140 / F2054), dye penetration (F1929)	5–7 business days	Available
Visual inspection (F1886) & bubble emission (F2096)	5–7 business days	Available
Microbial barrier (ISO 11607-1 Annex B)	10–14 business days	On request
Distribution simulation (ASTM D4169 / ISTA 2A / 3A)	10–15 business days	On request
Accelerated ageing programme	Duration per client validation protocol (ASTM F1980 Q10 / reference-temp calculation; client-specified shelf-life claim)	— driven by validation protocol
Gap-fill / regulatory response packaging addendum	48–72 hours	Express only

Who Needs Packaging Validation

All sterile medical device manufacturers — packaging validation is a mandatory element of every CDSCO, FDA 510(k), and EU CE technical file for sterile devices.
Class C / Class D implant manufacturers (orthopaedic, cardiovascular, ophthalmic) needing long shelf-life (3–5 year) sterile barrier validation.
Single-use disposable manufacturers (syringes, catheters, IV sets, surgical kits, wound dressings) running new-product validation and routine surveillance.
IV set and transfusion-set manufacturers needing combined SBS validation alongside their blood-bag / IS 12065 work.
Companies introducing packaging changes — material, sealing parameter, geometry, or sterilisation method — that trigger ISO 11607-2 re-validation.
Contract packagers establishing IQ / OQ / PQ for new sealing equipment under ISO 11607-2:2019.
Quality teams running periodic ASTM F1980 / real-time ageing surveillance for shelf-life confirmation.
Sterility-assurance teams correlating ISO 11607 packaging data with bioburden, ETO residuals, and final sterility — packaging is the prerequisite for the sterility claim.
Regulatory consultants assembling MDR 2017/745 technical files, FDA 510(k) sterility packages, and CDSCO Form MD-9 / MD-15 dossiers.
Post-market complaint investigation teams responding to channel-leak, dye-penetration, or returned-unit integrity findings.

Why Auriga for Packaging Validation

NABL-accredited packaging validation

Packaging validation testing — ISO 11607-1 / -2, ASTM F88, F1140, F1929, F1886 — performed under NABL ISO/IEC 17025:2017 accreditation, formatted for direct attachment to CDSCO, FDA, and CE Notified Body submissions.

Current 2019 editions of ISO 11607-1 & -2

We test and report against the harmonised ISO 11607-1:2019 and ISO 11607-2:2019 — the editions referenced under EU MDR, FDA recognised consensus standards, and CDSCO MDR 2017.

In-house calibrated ageing chambers

Calibrated, qualified temperature / humidity chambers run accelerated ageing protocols (per the client validation protocol and Q10 calculation) with concurrent real-time controls. Time-point reports are issued progressively so your launch dossier is not held up by the back-end of a long-shelf-life programme.

Bundled with bioburden, ETO residuals, sterility

Packaging validation is requested alongside bioburden, ETO residuals, and sterility on every sterile-device file — Auriga runs all four under one project lead, eliminating the data-reconciliation overhead of split-lab programmes.

Distribution simulation per ASTM D4169 / ISTA

Full ASTM D4169 and ISTA 2A / 3A distribution-simulation capability for both domestic and export packaging qualification.

Arbro Group analytical heritage

Established analytical heritage through the Arbro Group (Arbro Lab since 1990, Auriga Research since 2007), with NABL ISO/IEC 17025 accreditation — the audit trail medical device, contract packager, and sterility-assurance teams look for in a packaging-validation partner.

Related Services

Frequently Asked Questions

What packaging tests are required for sterile medical devices?

Sterile medical device packaging must be validated per ISO 11607-1:2019 (materials, sterile barrier system, and packaging system requirements) and ISO 11607-2:2019 (validation requirements for forming, sealing, and assembly processes). Key tests include seal strength per ASTM F88, burst testing per ASTM F1140 / F2054, dye penetration per ASTM F1929, visual seal inspection per ASTM F1886, microbial barrier testing per ISO 11607-1 Annex B, accelerated ageing per ASTM F1980, and distribution simulation per ASTM D4169 or ISTA protocols. CDSCO, FDA, and EU MDR all require packaging validation data as part of the sterile device submission dossier.

Does Auriga test per ISO 11607:2019 (the current edition) or the older 2006 version?

Auriga tests per the current ISO 11607-1:2019 and ISO 11607-2:2019 — the harmonised editions referenced under EU MDR 2017/745, FDA recognised consensus standards, and CDSCO MDR 2017 expectations. The 2019 revision substantially clarified the distinction between the sterile barrier system (SBS) and the protective / shipping package, formalised usability requirements for aseptic opening, and tightened the design and process-validation workflow. Reports always cite the exact ISO 11607 part and edition applied so reviewers can verify against the regulator's expected version.

How does accelerated ageing per ASTM F1980 work, and how long does it take?

Accelerated ageing per ASTM F1980 uses elevated temperature to simulate real-time shelf-life with a Q10 / Arrhenius relationship. The actual duration is calculated from the parameters defined in the client validation protocol — chosen Q10, accelerated and reference temperatures, and the shelf-life claim — and is not a fixed value the lab sets. As an illustrative calculation, with Q10 = 2 at 55 °C from a 23 °C reference a 1-year claim works out to roughly 38 days, a 2-year claim to roughly 76 days, and a 3-year claim to roughly 114 days; different Q10 or reference temperatures change these durations. Concurrent real-time ageing must be initiated at the same time so accelerated data supports the launch claim and real-time data progressively confirms the accelerated result over the shelf life. At the end of the accelerated and real-time intervals, seal strength, dye penetration, visual inspection, and microbial barrier (where applicable) are repeated to confirm the SBS is intact.

What is the difference between seal strength and burst testing?

Seal strength testing (ASTM F88) measures the force required to peel open a sealed pouch — it evaluates the consistency and adequacy of the heat seal as a process-control parameter. Burst testing (ASTM F1140 for unrestrained, ASTM F2054 for restrained) pressurises the package internally until failure, testing the overall package integrity at the weakest point. Both tests are complementary: seal strength verifies sealing process control across the population of seals; burst testing detects gross leaks, channels, and weak spots that ASTM F88 strip-by-strip testing can miss. ISO 11607-2:2019 expects both as part of a validated sealing process.

What sample quantity is required for an ISO 11607 packaging validation programme?

Sample quantity depends on the validation scope. A typical ISO 11607-2 process validation (IQ/OQ/PQ) requires 30–90 finished packages per process condition (3 lots × 3 conditions × 10 packages is a common minimum). Accelerated ageing per ASTM F1980 needs at least 30 packages per ageing time-point (test plus real-time control). Distribution simulation per ASTM D4169 / ISTA requires 6–10 packages per protocol. A full new-product PQ + 3-year shelf-life programme typically uses 200–300 packages staged across time-points. Confirm exact quantities with your SPOC at the quote stage — particularly when high-value implantable packaging is involved.

What is the regulatory consequence of inadequate packaging validation data?

Packaging validation deficiencies are among the most common reasons for sterile-device submission delays. (1) CDSCO MD-9 / MD-15 applications without ISO 11607-1 / -2:2019 sterile barrier validation and ASTM F1980 ageing data are returned with a sterility-assurance deficiency — typically blocking the registration by 3–6 months. (2) FDA 510(k) submissions where the package data does not align with the sterility section trigger an Additional Information (AI) request. (3) EU MDR technical files lacking ISO 11607:2019 conformity are a leading Notified Body non-conformance. (4) Post-market: a packaging integrity failure in distributed product (channel leaks, dye penetration in returned units) triggers CDSCO Materiovigilance / FDA MAUDE reporting and a full recall. The sterile barrier system is the last line of defence — a robust validation is materially cheaper than reacting to a sterility excursion.

Can Auriga support contesting a CDSCO, FDA, or Notified Body finding on packaging with additional data?

Yes. Gap-fill packaging testing in response to a CDSCO deficiency, FDA AI request, or Notified Body non-conformance is a routine workflow. The path is: (1) review the regulator's specific finding with your SPOC; (2) identify whether the gap requires additional seal-strength batches, fresh dye penetration, an accelerated ageing top-up, or a distribution-simulation overlay; (3) run the targeted top-up programme — not a full re-validation; (4) issue an NABL-accredited supplementary packaging report formatted as an addendum to the original ISO 11607 file. Express 48–72 hour turnaround is available for time-critical regulatory response windows.

Get a Tailored Recommendation

Talk to a Testing Expert